Immune Defect Detected in Knockout Mice

Researchers have identified a mutation in a commonly used commercial mouse strain that could impact experimental results.

Written byTanya Lewis
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

C57BL/6 mouseWIKIMEDIA, WUALEXScientists found a mutation in the C57Bl/6 mouse strain, which could affect the results of studies that have used the animals, STAT News reported today (May 20). The mutation disrupts the function of the Dock2 gene, causing immune effects, researchers from the Ragon Institute in Cambridge, Massachusetts, and colleagues wrote in the study, which was published yesterday (May 19) in Cell Reports.

“In light of these findings, published studies involving immune or hematopoietic phenotypes in which these C57BL/6 mice have been used as controls, as experimental animals, or for backcrossing will need to be reinterpreted,” the authors wrote in their paper.

The Ragon Institute’s Vinay Mahajan and colleagues previously observed a number of immune system defects in mice engineered to have a defective Siae gene, including a decrease in marginal zone B cells and an increase in CD8+ memory T cells. The researchers backcrossed these mice for several generations with C57Bl/6 mice purchased from lab animal supplier Harlan Sprague Dawley, and found that the resulting animals still had the same immune phenotype.

By sequencing whole genomes and examining single nucleotide polymorphisms (SNPs) of these mouse strains, the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform